Macrophage immunity to vaccinia virus was examined by measuring replication of vaccinia virus in immune and nonimmune rabbit peritoneal macrophages. Vaccinia virus multiplied in macrophages from normal rabbits but failed to replicate in macrophages from immune rabbits. The specificity of vaccinia restriction was demonstrated by the ability of myxoma virus to replicate in nonimmune and vaccinia-immune macrophages. Vaccinia virus absorbed equally well to immune and nonimmune macrophages, but only a small fraction of immune cells supported synthesis of virus antigen. Virus eclipse and infective center neutralization studies suggested that much of the virus remained at the plasma membrane of immune macrophages, even after prolonged incubation in culture. These data support our previous suggestions that macrophages may contribute to specific immunity against vaccinia virus.
Macrophage immunity to vaccinia virus was examined by measuring replication of vaccinia virus in immune and nonimmune rabbit peritoneal macrophages. Vaccinia virus multiplied in macrophages from normal rabbits but failed to replicate in macrophages from immune rabbits. The specificity of vaccinia restriction was demonstrated by the ability of myxoma virus to replicate in nonimmune and vaccinia-immune macrophages. Vaccinia virus absorbed equally well to immune and nonimmune macrophages, but only a small fraction of immune cells supported synthesis of virus antigen. Virus eclipse and infective center neutralization studies suggested that much of the virus remained at the plasma membrane of immune macrophages, even after prolonged incubation in culture. These data support our previous suggestions that macrophages may contribute to specific immunity against vaccinia virus.
There is much evidence to suggest that the cellular elements of the immune response act as a major factor in the control of a number of virus infections (1, 3, 8, 13) . Macrophages, by virtue of their ability to interact with and phagocytose viruses, can in some instances restrict replication and spread of the virus (6, 13, 21) . It is generally believed that this macrophage function does not require prior sensitization of the animal but reflects a nonimmunological resistance on the part of the macrophage.
Macrophages may also be instrumental in cell-mediated immunological resistance to virus infection. Reports on in vitro studies of resistance of macrophages to infection by poxviruses have been inconclusive. Whereas Roberts (11) reported an apparent increase in susceptibility of immune macrophages to ectromelia virus, other investigators have found no difference in susceptibility of macrophages from immune and nonimmune animals to poxviruses (13) . Others have, on the other hand, demonstrated that macrophages from immune animals are more resistant to virus replication than macrophages from normal animals (14, 18) . These differences may reflect individual variations in virus-host systems, methods of immunization, and assays of immunity.
Previous studies by Tompkins et al. (18) demonstrated that purified peritoneal macrophages from rabbits sensitized to vaccinia virus were specifically inhibited by vaccinia virus in 9 the migration-inhibition test. Further attempts to investigate this macrophage-associated immunity showed that macrophages from vacciniaimmune rabbits suppressed replication of vaccinia virus, whereas normal macrophages did not.
The present study was designed to extend these observations and explore the basic interaction in tissue culture between vaccinia virus and immune macrophages.
MATERIALS AND METHODS
Tissue culture cells and media. Primary rabbit kidney cells were prepared by trypsinization of kidneys from 2-to 4-week-old New Zealand White rabbits. RK, cells, an established line of rabbit kidney cells, were obtained from Grand Island Biological Co. All cells were grown in Eagle's medium supplemented with 10% newborn calf serum, penicillin (100 units/ml), streptomycin (100 ,g/ml), and sodium bicarbonate.
Preparation of virus stocks. The WR strain of vaccinia virus was grown in monolayers of primary rabbit kidney (PRK) cells in 16-oz (473-ml) prescription bottles. Cell monolayers were inoculated with 107 plaque-forming units (PFU) of virus and allowed to absorb for 2 hr at room temperature, after which 20 ml of medium was added and the cultures were incubated at 37 C for 48 hr. The virus was AVILA, SCHULTZ, AND TOMPKINS counting method on monolayers of RK1 cells without an overlay.
Immunization of rabbits. Young-adult, male New Zealand White rabbits, 12 to 18 weeks of age, were immunized by inoculating 0.1 ml (106 PFU) of vaccinia virus intradermally at four sites on their shaved backs. The rabbits were given a second identical inoculation 3 to 4 weeks later. A delayed cutaneous reaction at the site of inoculation was taken as evidence that the rabbits had been sensitized. Rabbits were used in experiments 1 to 2 weeks after the second inoculation of virus.
Preparation of peritoneal macrophages. Peritoneal exudate cells were obtained from rabbits after injection of paraffin oil as previously described (16, 18) . Purified macrophages were obtained by placing the exudate cells in 16-oz prescription bottles in 10 ml of Eagle's medium and incubating for 10 to 15 min at 37 C. The unattached cells were removed, and the adhering macrophages were washed three times with cold Hanks balanced salt solution (HBSS) at pH 7.2 to 7.4. The adhering cells were then gently scraped from the glass surface in Eagle's medium, washed, and counted in a hemacytometer. Macrophages were kept in an ice bath prior to use to prevent adherence to the glass surface. This procedure usually resulted in a yield of 2 X 107 to 8 X 107 macrophages for each rabbit, with a viability of 90% or greater.
Inoculation of macrophages with virus. Virus was adsorbed to macrophages in a 1-ml suspension for 90 min at 4 C with frequent shaking. Nonadsorbed virus was removed by two washes in medium, and the cells were resuspended to a concentration of 2.5 X 101 cells/ml. For growth curve experiments, 1-ml portions were placed in loose-capped culture tubes and incubated at 37 C in the presence of 5% CO2 in air. Duplicate samples were frozen at the beginning of the experiment and at the intervals to be tested. Virus to be assayed was released from the cells by three cycles of freeze-thawing, the duplicate tubes were pooled, and the virus was titered by plaquing on monolayers of RK1 cells.
Assay of infective centers. Macrophages free in the medium and macrophaages removed from the glass surface by trypsin (0.25%) were pooled from duplicate tubes, washed three times with HBSS, resuspended in Eagle's medium, and counted. Appropriate dilutions of each sample were prepared, and 100 or 1,000 cells were plated onto monolayers of RK1 cells in 1-oz (ca. 30-ml) prescription bottles. After 30 min at 37 C had been allowed for macrophages to adhere to the monolayers, the cultures were covered with 1% agar overlay and incubated at 37 C. Plaques were counted after 72 hr.
Neutralization of infective centers. To neutralize virus adherent to the cell membrane, macrophages were prepared as above. However, before plating, the washed cells were resuspended in 1 ml of a 1:4 dilution of antivaccinia serum or normal serum in HBSS and were incubated for 1 hr at 4 C with frequent shaking. After incubation, the cells were washed twice in cold HBSS and plated for infective center assay as described above. Vaccinia immune serum prepared in rabbits (50% virus neutralizing titer, 1:1,024) and in guinea pigs (50% virus neutralizing titer, 1:512) were used in this test. Immnunofluorescence test. Infected and noninfected macrophages were seeded onto cover slips in shell vials in 2 ml of Eagle's medium and were incubated at 37 C in a 5% CO2 in air atmosphere. At intervals after seeding, duplicate cover slips were prepared for the indirect immunofluorescence test as described (17) . Briefly, the monolayers were washed twice in pH 7.6 tris(hydroxymethyl)aminomethane-buffered saline (TBS), allowed to air-dry, and fixed in acetone for 3 min at room temperature. Standard heat-inactivated (30 min at 56 C) vaccinia-immune and normal rabbit sera diluted 1:4 in TBS were used throughout the study. Fixed cell monolayers were treated with antiserum for 30 min at 37 C, washed three times in TBS (5 min/wash), and counterstained for 30 min at 37 C with fluorescein-conjugated goat anti-rabbit gamma globulin. The cells were washed three times, mounted in TBS-glycerol, and observed with a Zeiss fluorescence microscope. plasmic granulation (Fig. 2a) . Furthermore, it was evident from these studies that immune cells had a tendency to spread on the glass surface with distinct pseudopod formations, whereas normal macrophages tended to remain rounded with few visible pseudopods.
RESULTS

Replication of vaccinia virus and myxoma virus
Adsorption of vaccinia virus to immune and nonimmune macrophages. In an attempt to explain the differences in susceptibility of immune and nonimmune macrophages to vaccinia virus, experiments were designed to test for differences in adsorption. Macrophages were inoculated with 0.1 PFU of virus per cell and were washed to remove residual virus; the total adsorbed virus and the fraction of cells adsorbing virus were then measured. The data recorded in Table  1 (Fig. 3b) . Immuno The growth curve of vaccinia virus i mune macrophages showed only a sligi between 0 and 6 hr, with a continuous in virus titers thereafter, suggesting a phase of approximately 6 hr (Fig. 4) Virus adsorption studies showed the fraction of cells adsorbing virus and the total virus adsorbed to be the same for immune and nonimmune macrophages. In agreement with this, Steinberger and Rights (14) showed no difference in uptake of vaccinia virus by spleen cells from immune and nonimmune rabbits, and Glasgow (5) demonstrated that chikungunya virus adsorbed to peritoneal leukocytes from immune and nonimmune mice at identical rates. These results argue against any alteration in capacity of macrophages to adsorb virus, after immunization. Furthermore, since the number of cells registering infectious virus was as large and the total amount of virus adsorbed to immune macrophages was not less than that adsorbed to normal macrophages, the virus apparently is not neutralized after adsorption to immune macrophages.
Although there is no difference in adsorption of virus by immune and nonimmune macrophages, subsequent events in the virus replication cycle are different. Infective center studies revealed that essentially all of the macrophages in the normal cell population were susceptible to virus infection. Similarly, immunofluorescence studies showed accumulation of virus antigen in the cytoplasm of most of the normal macrophages by 48 hr after infection. In contrast, the infection of cultures of immune macrophages did not appear to spread from the cells originally adsorbing virus. Indeed, there was a decrease in the fraction of cells associated with infectious virus between 0 and 72 hr after infection. Decrease in infective centers with time could represent thermal inactivation of virus, gradual elution of virus from the surface of the cell, or active neutralization or degradation on the part of the immune macrophage. At the present time, we have no information on which of these or other mechanisms may be operable. Immunofluorescence studies also demonstrated that only a small fraction of cells (< 1%) in the immune macrophage population supported the synthesis of virus antigens. The number of cells with virus antigens appeared to remain relatively constant throughout the experiment and was always significantly less than the number of cells shown to carry infectious virus by the infective center assay. It is possible that these cells represent a small number of susceptible contaminating fibroblasts which are always present in our macrophage preparations. In any event, we can conclude from these data that only a small fraction of cells in the immune macrophage population are susceptible to virus infection and that, for the most part, adsorption of virus to immune cells does not lead to production of virus antigen or infectious virus. This is in contrast to observations made on nonimmune abortive infections of macrophages with herpesvirus, which result in the production of virus antigens and incomplete virus particles but no infectious virus (15) .
Although vaccinia virus can be shown to eclipse in normal macrophages, no evidence of uncoating was found after adsorption of virus to immune macrophages. Furthermore, it was observed that a high percentage of immune macrophage infective centers at 24 and 48 hr after infection were rendered noninfectious by treatment with vaccinia-immune serum. In the case of nonimmune macrophages, immune serum was significantly less effective in neutralizing infective centers after 24 hr of incubation at 37 C, suggesting that much of the infectious virus was intracellular at that time. We have no explanation for the apparent fixation of vaccinia virus at the surface of immune macrophages. Unanue and Cerottini (19) observed that a small fraction of soluble antigens such as hemocyanin remains bound to the plasma membrane of macrophages even after prolonged incubation in vitro. Enhancement of pinocytosis with heparin or dextrose sulfate did not result in endocytosis of these molecules. However, there has been no previous evidence to suggest retention of particulate antigens at macrophage membranes (20) . These studies for the most part differ from the present study in that they were not dealing with immune macrophages or infectious virus which may bind to specific cellular receptors. Under these conditions, the normal phagocytic or pinocytic events may not occur, or these virus-binding areas may not participate in endocytosis.
Although it has been reported that macrophages activated by bacterial infections have enhanced phagocytic capabilities (7), recent in vitro studies have demonstrated that peritoneal macrophages from Candida albicans-sensitized guinea pigs had a decreased ability to phagocytose C. albicans (9, 12) . This unexpected observation led the authors to propose that cellular immunity to C. albicans is associated with reduced activity of phagocytic macrophages, thereby promoting localization of the lesions (12) . A similar mechanism may be operative in the case of vaccinia virus and rabbit macrophages. It 
